Trade LONA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
LeonaBio, Inc. (LONA) is trading at US$6.92, up 0.87% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$72.41M. Over the past 52 weeks, LONA has traded between US$3.55 and US$14.21. On Syfe you can trade LONA with $0 commission and add it to your watchlist.
| Previous close | US$6.86 |
|---|---|
| Market cap | US$72.41M |
| 52-week range | US$3.55 – US$14.21 |
| Volume | 42.65K |
| Exchange | US |
Add to Watchlist
Set Price Alert
LeonaBio, Inc.
LeonaBio, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.
Year: 2020
--Piper Sandler Initiates LeonaBio at Overweight
May 27, 10:42 AM · MT Newswires
--Mizuho Raises Price Target on LeonaBio to $16 From $10, Keeps Outperform Rating
Apr 6, 10:27 AM · MT Newswires
LeonaBio, Inc. (LONA) stock is trading at US$6.92, +0.87% from the previous close of US$6.86.
The market cap for LeonaBio, Inc. (LONA) stock is approximately US$72.41M.
The 52-week high for LeonaBio, Inc. (LONA) stock is US$14.21.
The 52-week low for LeonaBio, Inc. (LONA) stock is US$3.55.
LeonaBio, Inc. (LONA) does not currently pay a dividend.
Stay on top of LONA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
